- Purpose and Use of This Guideline
- Risk of Infection Following an Exposure to HIV
- Rationale for PEP and Evidence of PEP Effectiveness
- First Dose of PEP and Management of the Exposure Site
- Exposure Risk Evaluation
- Source HIV Status and Management
- Baseline Testing of the Exposed Individual
- Selecting and Initiating a 28-Day Course of PEP
- Counseling and Patient Education
- Providing PEP Medications and Other Services
- Follow-Up of the Exposed Individual
- Sequential HIV Testing and Laboratory Monitoring
- Management of Potential Exposure to Hepatitis B Virus
- Management of Potential Exposure to Hepatitis C Virus
- All Recommendations
- All Good Practices
- All Tables, Figures, and Boxes
- Supplementary Materials
- How This Guideline Was Developed
- Updates to This Guideline
PEP TO PREVENT HIV INFECTION
The Medical Care Criteria Committee produces the PEP guidelines
- Dr. Elliot E. DeHaan, lead author of the 2020 PEP to Prevent HIV Infection guideline, talks with TheBodyPro about the new guideline → Read the interview
- Subscribe to our mailing list to be notified when new or updated guidelines are published → Sign up now